Please Wait
Applying Filters...
menu
    • menu
    Coral

    Virtual Booth

    Contact Supplier

    China’s top API & intermediate manufacturer, delivering advanced CMO/CDMO solutions to 60+ countries, empowering global health progress

    Virtual Booth

    Contact Supplier

    AMI Lifesciences is Driven by Chemistry. Powered by People.

    Virtual Booth

    Contact Supplier

    ChemWerth works in generic API development & supply, non-infringement patent strategy development and regulatory support.

    Virtual Booth

    Contact Supplier

    Alchem offers Botanical APIs for Pharmaceuticals, Cosmetics and Nutraceuticals// FDA-inspected and EU-GMP certified.

    Virtual Booth

    Contact Supplier

    pharmacompass-2-m-2026-04-20

    Virtual Booth

    An Enquiry

    Menu

    boron citrate/aspartate/glycinate

    ACTIVE PHARMA INGREDIENTS

    INTERMEDIATES

    FINISHED DOSAGE FORMULATIONS

    DIGITAL CONTENT

    MARKET PLACE

    PharmaCompass
    Xls

    Filters

    clear-filterReset all filters
    Left Arrow
    Right Arrow

    Digital Content read-more

    Create Content with PharmaCompass, ask us

    NEWS #PharmaBuzz

    read-more
    read-more
    AN2 Therapeutics to Present at Jefferies Healthcare Conference
    AN2 Therapeutics to Present at Jefferies Healthcare Conference

    21 May 2026

    // BUSINESSWIRE

    https://www.businesswire.com/news/home/20260521162598/en/AN2-Therapeutics-to-Present-at-2026-Jefferies-Global-Healthcare-Conference

    BUSINESSWIRE
    21 May 2026
    Share Share
    Shukra Pharma Gets YEIDA Loi For Rs 600-Crore Facility
    Shukra Pharma Gets YEIDA Loi For Rs 600-Crore Facility

    06 Feb 2026

    // ECONOMICTIMES

    https://economictimes.indiatimes.com/industry/healthcare/biotech/pharmaceuticals/shukra-pharma-gets-yeida-loi-for-rs-600-crore-facility/articleshow/127978677.cms

    ECONOMICTIMES
    06 Feb 2026
    Share Share
    GSK & AN2 Partner on Boron-Based LeuRS Inhibitors for TB
    GSK & AN2 Partner on Boron-Based LeuRS Inhibitors for TB

    10 Nov 2025

    // BUSINESS WIRE

    https://www.businesswire.com/news/home/20251110907693/en/AN2-Therapeutics-Announces-Research-Collaboration-With-GSK-to-Advance-Boron-Based-LeuRS-Inhibitors-Targeting-Tuberculosis-TB

    BUSINESS WIRE
    10 Nov 2025
    Share Share
    AN2 Therapeutics Joins Fireside Chat At Evercore HealthCONx
    AN2 Therapeutics Joins Fireside Chat At Evercore HealthCONx

    06 Nov 2025

    // BUSINESS WIRE

    https://www.businesswire.com/news/home/20251106433022/en/AN2-Therapeutics-to-Participate-in-Fireside-Chat-at-Evercore-HealthCONx-Conference

    BUSINESS WIRE
    06 Nov 2025
    Share Share
    TAE Life BNCT Drugs + ICI Show Tumor Inhibition in Preclinical
    TAE Life BNCT Drugs + ICI Show Tumor Inhibition in Preclinical

    29 Sep 2025

    // BUSINESSWIRE

    https://www.businesswire.com/news/home/20250929560129/en/TAE-Life-Sciences-Novel-Boronated-Drugs-for-BNCT-in-Combination-with-Immune-Checkpoint-Inhibitors-Demonstrate-Superior-Tumor-Growth-Inhibition-in-Preclinical-in-vivo-Models

    BUSINESSWIRE
    29 Sep 2025
    Share Share
    AN2 Therapeutics Reports Phase 3 Data from EBO-301 Study
    AN2 Therapeutics Reports Phase 3 Data from EBO-301 Study

    01 May 2025

    // BUSINESSWIRE

    https://www.businesswire.com/news/home/20250501810086/en/AN2-Therapeutics-Reports-Data-from-the-Phase-3-Portion-of-Previously-Terminated-EBO-301-Study-and-Outlines-Future-Milestones-from-Boron-Chemistry-Pipeline

    BUSINESSWIRE
    01 May 2025
    Share Share
    • Privacy policy
    • Terms and conditions
    • Disclaimers
    • LinkedIn
    • Product listings are provided for informational purposes only. We do not supply or sell any products. Any products that may be covered by patent(s) are supplied solely for uses permitted under Section 107A of the Indian Patents Act and not for commercial sale.